Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above

Cholesterol Lowering ◽

Cholesterol Levels ◽

Association between Lowering Low-Density Lipoprotein Cholesterol with Pravastatin and Primary Prevention of Cardiovascular Disease in Mild to Moderate Hypercholesterolemic Japanese

Journal of Atherosclerosis and Thrombosis ◽

10.5551/jat.4176 ◽

2010 ◽

Vol 17 (8) ◽

pp. 879-887 ◽

Cited By ~ 19

Author(s):

Tamio Teramoto ◽

Noriaki Nakaya ◽

Shinji Yokoyama ◽

Yasuo Ohashi ◽

Kyoichi Mizuno ◽

...

Keyword(s):

Cardiovascular Disease ◽

Primary Prevention ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Cardiovascular disease risk associated with elevated lipoprotein(a) attenuates at low low-density lipoprotein cholesterol levels in a primary prevention setting

European Heart Journal ◽

10.1093/eurheartj/ehy334 ◽

2018 ◽

Vol 39 (27) ◽

pp. 2589-2596 ◽

Cited By ~ 37

Author(s):

Rutger Verbeek ◽

Renate M Hoogeveen ◽

Anne Langsted ◽

Lotte C A Stiekema ◽

Simone L Verweij ◽

...

Keyword(s):

Cardiovascular Disease ◽

Primary Prevention ◽

Disease Risk ◽

Cardiovascular Disease Risk ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Cholesterol Levels

low Density Lipoprotein Cholesterol Levels Among Patients with Clinical Atherosclerotic Cardiovascular Disease and Heterozygous Familial Hypercholesterolemia Post Statin Therapy

Value in Health ◽

10.1016/j.jval.2016.03.155 ◽

2016 ◽

Vol 19 (3) ◽

pp. A58

Author(s):

BH Johnson ◽

MM Bonafede ◽

N Princic ◽

DJ Harrison ◽

B Boatman ◽

...

Keyword(s):

Cardiovascular Disease ◽

Statin Therapy ◽

Familial Hypercholesterolemia ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Atherosclerotic Cardiovascular Disease ◽

Low Density ◽

Cholesterol Levels

Low-Density Lipoprotein Cholesterol Reduction and Prevention of Cardiovascular Disease

Mayo Clinic Proceedings ◽

10.1016/s0025-6196(11)60537-5 ◽

2009 ◽

Vol 84 (4) ◽

pp. 307-309 ◽

Cited By ~ 5

Author(s):

Evan A. Stein

Keyword(s):

Cardiovascular Disease ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Cholesterol Reduction ◽

Letter by Koh Regarding Article, “Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up”

Circulation ◽

10.1161/circulationaha.117.033136 ◽

2018 ◽

Vol 137 (22) ◽

pp. 2417-2418

Author(s):

Kwang Kon Koh

Keyword(s):

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Prevention Study ◽

Cholesterol Levels ◽

Scotland Coronary Prevention Study ◽

Faculty Opinions recommendation of Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.730917633.793539898 ◽

2017 ◽

Author(s):

Wilbert Aronow

Keyword(s):

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Prevention Study ◽

Cholesterol Levels ◽

Scotland Coronary Prevention Study ◽

RELATIONSHIP BETWEEN PERCENTAGE REDUCTION IN LOW-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS AND MAJOR ATHEROSCLEROTIC CARDIOVASCULAR DISEASE AMONG PATIENTS TREATED WITH STATINS +/- ALIROCUMAB OR EZETIMIBE IN THE PHASE 3 ODYSSEY TRIALS

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(16)32083-6 ◽

2016 ◽

Vol 67 (13) ◽

pp. 2082 ◽

Cited By ~ 1

Author(s):

Kausik Ray ◽

Henry Ginsberg ◽

Michael Davidson ◽

Robert Pordy ◽

Laurence Bessac ◽

...

Keyword(s):

Cardiovascular Disease ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Atherosclerotic Cardiovascular Disease ◽

Low Density ◽

Percentage Reduction ◽

Phase 3 ◽

Cholesterol Levels

Metabolic Syndrome is Strongly Associated With Chronic Subclinical Inflammation in Patients Achieving Optimal Low-Density Lipoprotein-Cholesterol Levels in Secondary Prevention of Cardiovascular Disease

Circulation Journal ◽

10.1253/circj.cj-08-0337 ◽

2008 ◽

Vol 72 (12) ◽

pp. 2046-2050 ◽

Cited By ~ 23

Author(s):

Yoshiki Matsuo ◽

Toshikazu Hashizume ◽

Shusaku Shioji ◽

Takashi Akasaka

Keyword(s):

Cardiovascular Disease ◽

Metabolic Syndrome ◽

Secondary Prevention ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Low Density ◽

Subclinical Inflammation ◽

Cholesterol Levels ◽

Intensive Lowering of Low-Density Lipoprotein Cholesterol Levels for Primary Prevention of Coronary Artery Disease

Mayo Clinic Proceedings ◽

10.1016/s0025-6196(11)60544-2 ◽

2009 ◽

Vol 84 (4) ◽

pp. 345-352 ◽

Cited By ~ 24

Author(s):

Dean G. Karalis

Keyword(s):

Coronary Artery Disease ◽

Coronary Artery ◽

Primary Prevention ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Cholesterol Levels ◽

Artery Disease

From intensive statins to intensive lipid lowering: Amplitude of low-density lipoprotein-cholesterol lowering is the core for atherosclerosis cardiovascular disease prevention

Cardiology Plus ◽

10.4103/cp.cp_27_18 ◽

2018 ◽

Vol 3 (4) ◽

pp. 122

Author(s):

Daoquan Peng

Keyword(s):

Cardiovascular Disease ◽

Disease Prevention ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Lipid Lowering ◽

Low Density ◽

Cholesterol Lowering ◽

The Core